Morocco - Healthcare, Regulatory and Reimbursement Landscape

Morocco - Healthcare, Regulatory and Reimbursement Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report "Morocco - Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Morocco. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Morocco is an emerging player in the global pharmaceutical market. In 2019, Moroccos pharmaceutical industry exported around 11% of national production to Europe, America, Asia, and Africa, indicating the importance of this industry, which is ranked second among the African continents after South Africa in terms of quality. In terms of Moroccan Dirhams, the country’s pharmaceutical market increased from MAD 9.31B in 2015 to MAD 13.83B in 2020, at a Compound Annual Growth Rate (CAGR) of 8.2%. In the terms of US dollars, the Moroccan pharmaceutical market increased from $1.02B in 2015 to $1.49B in 2020, at a CAGR of 6.5%. Morocco’s stable political environment and strategic location in the Mediterranean region, which connects Sub-Saharan Africa, the Middle East, and Europe, are intended to alleviate countrys pharmaceutical and healthcare industry in the next decade. The medical devices market in Morocco was valued at $270.2M in 2015, which decreased to $240.7M in 2020 at a negative CAGR of 2.3%. Morocco is progressively exploring to develop trade in medical devices and supplies with new partners, including Turkey, Brazil, Argentina, and several Far East countries, all of which can provide a similar quality of devices and supplies at lower costs. In 2018, the Moroccan Telemedicine Society (Société Marocaine de Télémédecine, SMT), in association with the Ministry of Health and Mohammed VI University of Health Sciences, launched a National Telemedicine Initiative with an aim to cover 160 rural municipalities and nearly 2 million population to create a significant health territory by 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Morocco, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Pfizer, Novartis, Sanofi, and Sothema
- Profiles and SWOT analyses of the major players in the medical device market: Roche Diagnostics, Abbott, Fresenius, Zimmer Biomet, and Air Liquide Healthcare
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement landscape, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Moroccan healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Moroccan healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Moroccan healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1 Table of Contents

2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Morocco Healthcare Market
2.3 Key Highlights: Healthcare Startups in Morocco
2.4 Key Events: Morocco Healthcare Industry, 2015-2021
2.5 Key Events: Morocco Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Top Completed Deals by Value, 2020-2021
2.8 Country Profile, Morocco, 2020

3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Morocco
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Morocco
3.7 COVID-19 Epidemiology, Morocco
3.8 COVID-19 Impact and Developments, Government response to mitigate the impact of COVID-19 Morocco
3.9 COVID-19 Impact and Developments in the Healthcare Market, Morocco
3.10 COVID-19 Clinical Trials Landscape, Morocco
3.11 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers

6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Morocco, 2019-2021
6.2 Deal Analysis: Medical Device Market, Morocco, 2020-2021

7. HealthTech Landscape
7.1 HealthTech Landscape, Morocco
7.2 HealthTech Deals Landscape, Morocco
7.3 Key HealthTech Deals, Morocco
7.4 Adoption of Technology in Healthcare, Morocco
7.5 Digital Health Regulations, Morocco
7.6 Digital Health: Benefits and Risks, Morocco

8. Market Access
8.1 Overview of Healthcare System, Morocco
8.2 Reimbursement Process, Morocco
8.3 Overview of Insurance Providers, Morocco
8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Morocco
8.5 Pricing Policies, Morocco
8.6 Regulatory Landscape, Morocco
8.6.1 Overview of Regulatory Agencies, Morocco
8.6.2 Marketing Authorization for Pharmaceutical Products, Morocco
8.6.3 Marketing Authorization for Biosimilars, Morocco
8.6.4 Marketing Authorization for Medical Devices, Morocco
8.6.5 Intellectual Property Rights, Patent, Morocco
8.6.6 Intellectual Property Rights, Trademark, Morocco
8.6.7 Clinical Trial Regulations, Morocco
8.6.8 Pharmaceutical Clinical Trials Landscape, Morocco
8.6.9 Medical Devices Clinical Trials Landscape, Morocco
8.6.10 Pharmacy License Regulations, Morocco
8.6.11 Pharmaceutical Advertising Regulations, Morocco
8.6.12 Labeling and Packaging Regulations, Morocco

9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Morocco
9.2 Healthcare Facilities, Morocco
9.3 Life Expectancy and Immunization Rate, Morocco
9.4 Environmental Health, Morocco
9.5 Healthcare Personnel, Morocco
9.6 Disease Burden, Morocco
9.7 Healthcare Expenditure, Morocco

10. Trade Associations, Morocco

11. Trade Fairs, Morocco

12. Opportunities and Challenges

13. Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer

List Of Tables

Table 1: List of Biosimilars Approved, Morocco, 2015-2019
Table 2: COVID-19 Indicators (Number of Cases), Morocco and Global, 2021
Table 3: COVID-19-Related Travel Restrictions, Morocco, 2020-2021
Table 4: Available COVID-19 Vaccines, Morocco, 2021
Table 5: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Morocco, 2020-2021
Table 6: Legal Frameworks for e-Health, Morocco, 2019
Table 7: Patent Fees, Morocco, 2020
Table 8: Trademark Fees, Morocco, 2020
Table 9: Medical Devices Clinical Trials, Morocco, 2019-2021

List Of Figures

Figure 1: Pharmaceutical Market, Morocco, Revenue ($B and MAD B), 2013-2020
Figure 2: Medical Device Market, Morocco, Revenue ($M), 2015-2020
Figure 3: Healthcare Start-Ups in Morocco, 2020
Figure 4: Country Profile, Morocco, 2020
Figure 5: Pharmaceutical Market, Morocco, Revenue ($B), 2015-2020
Figure 6: Pharmaceutical Market, Morocco, Revenue Forecast ($B), 2021-2025
Figure 7: Significant Events in the Evolution of the Pharmaceutical Industry, Morocco, 1960-2020
Figure 8: Pharmaceutical Exports ($M), Morocco, 2011-2020
Figure 9: Top Export Partners, Morocco, 2020
Figure 10: Pharmaceutical Imports ($M), Morocco, 2011-2020
Figure 11: Top Import Partners, Morocco, 2020
Figure 12: Pharmaceutical Distribution Channels, Morocco, 2019
Figure 13: Generics Market, Revenue (MAD B and $B), Morocco, 2015-2020
Figure 14: Generic Drug Consumption Volume (Millions of Units), Morocco, 2015-2020
Figure 15: OTC Market, Revenue (MAD M and $M), Morocco, 2015-2019
Figure 16: OTC Market, Million Number of Units, Morocco, 2016-2019
Figure 17: Biosimilars Market, Revenue (MAD M and $M), Morocco, 2015-2019
Figure 18: Major Pharmaceutical Products in the Market, Revenue in $M and MAD M), Morocco, 2019
Figure 19: Major Therapeutic Areas by Pharmaceutical Sales ($M), Morocco, 2017-2019
Figure 20: COVID-19 (Number of Cases), Morocco, 2020-2021
Figure 21: COVID-19 (Number of Deaths), Morocco, 2020-2021
Figure 22: COVID-19 Fiscal Stimulus Timeline, Morocco, 2020-2021
Figure 23: COVID-19 Vaccine Administration, Number of Vaccines administered, Morocco, 2021
Figure 24: Medical Devices Market, Morocco, Revenue ($M), 2013-2020
Figure 25: Medical Devices Market, Morocco, Revenue ($B) of Major Companies, 2020
Figure 26: Deal Value ($M), Pharmaceutical Market, Morocco, 2019-2021
Figure 27: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Morocco, 2019-2021
Figure 28: Deal Count, Pharmaceutical Market, Morocco, 2019-2021
Figure 29: Top Therapy Areas by Deal Value ($M), Pharmaceutical Market, Morocco, 2019-2021
Figure 30: Top Therapy Areas by Deal Count, Pharmaceutical Market, Morocco, 2019-2021
Figure 31: M&A Deals by Quarter, Pharmaceutical Market, Morocco, 2019-2021 (by Value and by Number)
Figure 32: M&A Deals, Medical Device Market, Morocco, 2020-2021 (by Value and by Number)
Figure 33: Deal Value and Deal Count, Quarterly, Medical Devices Market, Morocco, 2020-2021
Figure 34: Top Equipment Sectors, Medical Devices Market, Morocco, 2020-2021
(by Value and by Number)
Figure 35: Organizational Chart, National Commission for the Protection of Personal Data (CNDP), Morocco, 2021
Figure 36: Moroccan Patient-Centered Health Information System - Global Architecture, 2019
Figure 37: Deal Count (Number of Deals), HealthTech, Morocco, 2019-2021
Figure 38: Organization of Healthcare System, Morocco, 2019
Figure 39: Number of Drugs Reimbursable by the Compulsory Health Insurance (AMO) Morocco, 2011-2020
Figure 40: Reimbursement Process, Morocco, 2019
Figure 41: Distribution of Population across Health Insurance Schemes, Morocco, 2016
Figure 42: Out-of-Pocket Spending ($ per Capita), Morocco, 2011-2020
Figure 43: Change in Pharmaceutical Price Index (% Change Accumulated in the Year), Morocco, 2014-2020
Figure 44: Organizational Structure, Ministry of Health, Morocco, 2019
Figure 45: Marketing Authorization of Pharmaceutical Products, Morocco, 2020
Figure 46: Marketing Authorization of Biosimilars, Morocco, 2020
Figure 47: Patent Approval Process, Morocco, 2020
Figure 48: Trademark Approval Process, Morocco, 2020
Figure 49: Clinical Trial Approval Process, Morocco, 2020
Figure 50: Pharmaceutical Clinical Trials Count by Trial Status, Morocco, 2019-2021
Figure 51: Pharmaceutical Clinical Trials Count by Phase, Morocco, 2019-2021
Figure 52: Pharmaceutical Clinical Trials Count by Indication, Morocco, 2019-2021
Figure 53: Pharmaceutical Clinical trials by Trial Sponsors, Morocco, 2019-2021
Figure 54: Pharmacy Regulations, Morocco, 2019
Figure 55: Labelling and Packaging, Morocco, 2019
Figure 56: Number of Public Hospitals, Morocco, 2013-2020
Figure 57: Hospital Beds Density (per 10,000 Population), Morocco, 2013-2020
Figure 58: Life Expectancy at Birth (Years), Morocco, 2013-2020
Figure 59: Immunization Rate (% of Children Ages 12-23 Months), Morocco, 2013-2019
Figure 60: PM2.5 (µg per m3), Morocco, 2012-2020
Figure 61: CO2 Emissions (Mt of CO2), Morocco, 2012-2020
Figure 62: Number of Physicians, Morocco, 2013-2020
Figure 63: Number of Nurses, Morocco, 2013-2020
Figure 64: Number of Dentists, Morocco, 2013-2020
Figure 65: Number of Pharmacists, Morocco, 2013-2020
Figure 66: Major Causes of Mortality (per 100,000 population), Morocco, 2019
Figure 67: Major Causes of Male Mortality (per 100,000 population), Morocco, 2019
Figure 68: Major Causes of Female Mortality (per 100,000 population), Morocco, 2019
Figure 69: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Morocco, 2019
Figure 70: Healthcare Expenditure as Percentage of GDP (%), Morocco, 2012-2020
Figure 71: Health Expenditure Share (% of Health Spending), Morocco, 2012-2020
Figure 72: Opportunities and Challenges

Fill The Form For Sample Request

There is no Reviews available